Spark Therapeutics, which is developing gene therapy treatments for orphan retinal dystrophies, raised $161 million in an upsized IPO by offering 7 million shares at $23, above the upwardly revised range of $19 to $21. Spark Therapeutics plans to list on the NASDAQ under the symbol [ONCE]. Spark Therapeutics initially filed confidentially on 9/24/2014. J.P. Morgan and Credit Suisse acted as lead managers on the deal....more
Shake Shack, a well-known upscale fast-casual burger chain with 63 restaurants across 31 cities and nine countries, raised $105 million by offering 5 million shares at $21, above the upwardly revised range of $17 to $19. The New York, NY-based company had initially filed to offer the same number of shares at a range of $14 to $16. At the offer price, Shake Shack commands a fully diluted market cap of $751 million (enterprise value of $680 million). Shake Shack will list on the NYSE under the symbol [SHAK]. J.P. Morgan, Morgan Stanley, Barclays, Goldman Sachs and Jefferies & Co. acted as ...more
Sol-Wind Renewable Power LP, which owns a portfolio of contracted solar generation assets, announced terms for its IPO on Thursday. The New York, NY-based company plans to raise $174 million by offering 8.7 million units at a price range of $19 to $21. At the midpoint of the proposed range, it would command a fully diluted market value of $401 million.
Renewable energy yieldco IPOs in 2014 included Abengoa Yield ([ABY]; +17%) and TerraForm Power ([TERP]; +30%), both of which priced above their proposed range.
Sol-Wind Renewable Power LP, which was founded in 2014 and booked $24 ...more
Inovalon Holdings, which provides healthcare analytics to payors, providers and pharmas, announced terms for its IPO on Thursday. The Bowie, MD-based company plans to raise $500 million by offering 22.2 million shares at a price range of $21 to $24. At the midpoint of the proposed range, Inovalon would command a fully diluted market value of $3.4 billion.
Last year's healthcare data IPO, TPG-backed IMS Health ([IMS]), trades 25% above its offer price.
Inovalon Holdings, which was founded in 1998 and booked $336 million in sales for the 12 months ended September 30, 2014, plans to ...more